CSF2 and neoplasm: The expression level of IL-12, GM-CSF, and RLX was significantly elevated in tumor tissues treated with RdB/IL12 or RdB/IL12/GMCSF-RLX + αPD-1 in tumor tissues (Figs. 3A to C).